BeyondSpring Inc.’s BYSI share price has dipped by 10.67%, which has investors questioning if this is right time to buy.

During a live event, Marc S. Hoffmann, MD, discussed outcomes from the SEQUOIA and ELEVATE-TN studies in chronic lymphocytic ...

Background The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on ...

with fluoropyrimidine-based chemotherapy for untreated metastatic colorectal cancer [ID6465] Technology appraisal guidance BI 1015550 for treating idiopathic pulmonary fibrosis or progressive ...

Lazertinib with amivantamab and platinum-based chemotherapy for EGFR mutation-positive metastatic ... Technology appraisal guidance Benegrastim for treating chemotherapy-induced neutropenia in people ...

The next drug Amgen brought to market in 1991 was Neupogen, a recombinant version of G-CSF (granulocyte colony-stimulating factor), that could be used to treat chemotherapy-induced neutropenia in ...

[11] investigated the time course of the changes in protein C concentrations in an oncology population at high risk of developing severe sepsis secondary to chemotherapy-induced neutropenia.

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, ...

Bayer will present new data for NUBEQA® (darolutamide) in prostate cancer at the upcoming American Urological Association (AUA) Annual Meeting taking place in Las Vegas from April 26-29, 2025. These ...

Evidence for chemotherapy-induced cognitive changes comes from studies that have used neuropsychological testing, imaging (structural and functional magnetic resonance imaging (MRI) and positron ...

Similarly, cerebellar changes correlate with memory complaints reported in other studies, where chemotherapy-induced ...